Trial Profile
Study to Evaluate Tolerability of Myfortic With Simulect Induction and Tacrolimus Without Steroids in Three Patient Populations; 1: Kidney/Pancreas Transplants,2: Diabetic Kidney Transplants, and 3: Non-diabetic Kidney Transplants
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Kidney-pancreas transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- 06 Jul 2011 New trial record